Main Industry
Biotechnology
Main Product/Service
Rock Bio’s Low-Sugar Universal Vaccine™ technology stems from pioneering glycoengineering research led by Professor Chi-Huey Wong and was recognized by IUPAC in 2023 as one of the Top 10 Emerging Technologies in Chemistry. This approach addresses viral im
Founded Year
2021
Unified Business No.
90255046
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,210,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Rock Bio: Harnessing the power of Glyco-Engineering for disease prevention and treatment Rock Bio is a Glyco-Engineering company dedicated to the development of better vaccines and antibody drugs through manipulation of sugar on the glycoproteins of inter